RB, W., & LJ, G. (2008). Identity of single-nucleotide polymorphisms used in a clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy: Comment on the article by Wessels et al. Arthritis & Rheumatism, 58(4), 1204. https://doi.org/10.1002/art.23414
Chicago Style (17th ed.) CitationRB, Warren, and Gibbons LJ. "Identity of Single-nucleotide Polymorphisms Used in a Clinical Pharmacogenetic Model to Predict the Efficacy of Methotrexate Monotherapy: Comment on the Article by Wessels Et Al." Arthritis & Rheumatism 58, no. 4 (2008): 1204. https://doi.org/10.1002/art.23414.
MLA (9th ed.) CitationRB, Warren, and Gibbons LJ. "Identity of Single-nucleotide Polymorphisms Used in a Clinical Pharmacogenetic Model to Predict the Efficacy of Methotrexate Monotherapy: Comment on the Article by Wessels Et Al." Arthritis & Rheumatism, vol. 58, no. 4, 2008, p. 1204, https://doi.org/10.1002/art.23414.